The fastest way to compare Medicare prescription drug plans is to go to medicare.gov/plan-compare, enter your specific medications and pharmacy, and sort by estimated total annual cost — not monthly premium. That single step eliminates most of the confusion, because a plan with a $0 premium can easily cost you more than one charging $40 a month if your drugs land on higher formulary tiers. In 2026, with standalone Part D plans dropping 22% from 464 to just 360 options, there are fewer choices but the stakes of picking the wrong one remain high. This matters especially for families managing dementia care.
Many people with Alzheimer’s or other cognitive conditions take multiple medications — cholinesterase inhibitors, memantine, plus drugs for blood pressure, diabetes, or blood clots — and the cost differences between plans can run into thousands of dollars annually. The good news: the Inflation Reduction Act has introduced a $2,100 annual out-of-pocket cap for 2026, down from what was effectively unlimited spending just two years ago. That alone is a significant safety net. But you still need to choose a plan that covers your drugs at reasonable tier levels, includes your pharmacy, and doesn’t hit you with surprise costs before you reach that cap. This article walks through exactly how to evaluate Part D plans for 2026, including what the new negotiated drug prices mean for your wallet, how formulary tiers actually work, where people commonly make mistakes, and what to do if you’re helping a parent or spouse who can no longer manage this process themselves.
Table of Contents
- What Should You Actually Look at When Comparing Prescription Drug Plans?
- How the $2,100 Out-of-Pocket Cap Changes the Math for 2026
- What Medicare’s Negotiated Drug Prices Mean for Your Prescriptions
- How to Use the Medicare Plan Finder Without Getting Overwhelmed
- Common Mistakes That Cost Dementia Families Money
- Free Vaccines and the Insulin Cap — Benefits Easy to Overlook
- Getting Help When the Person Who Needs Coverage Can’t Manage It Alone
- Conclusion
What Should You Actually Look at When Comparing Prescription Drug Plans?
Forget the premium. Or rather, don’t start there. The number that matters most is your estimated total annual cost, which includes the premium, the deductible, and every copay or coinsurance payment you’ll make over twelve months. In 2026, the maximum Part D deductible is $615, up from $590 in 2025. Some plans waive the deductible entirely for certain tiers, while others apply it to everything except generics. Two plans with the same $34 monthly premium can differ by over a thousand dollars depending on how they tier your specific medications. Here is what to compare, in order of importance.
First, check that every drug you take is on the plan’s formulary — the list of covered medications. If a drug isn’t on the formulary, you pay full price and those costs don’t count toward your $2,100 out-of-pocket cap. Second, look at which tier each drug falls on. Most plans use five tiers: Tier 1 for preferred generics at the lowest copay, Tier 2 for non-preferred generics, Tier 3 for preferred brand-name drugs, Tier 4 for non-preferred brands, and Tier 5 for specialty medications that can cost hundreds per fill. The same drug — say, Eliquis — might be Tier 3 on one plan and Tier 4 on another, which could mean the difference between a $47 copay and a $100 copay per month. Third, confirm your pharmacy is in the plan’s preferred network. Copays at preferred pharmacies are often 30-50% lower than at non-preferred ones, and mail-order programs can reduce costs further for maintenance medications. For someone managing a loved one’s dementia medications, mail-order can also simplify the logistics of keeping prescriptions filled on schedule.
How the $2,100 Out-of-Pocket Cap Changes the Math for 2026
The most significant change in recent Medicare history is the hard cap on annual drug spending. In 2025, Part D introduced a $2,000 out-of-pocket maximum. For 2026, that cap adjusts to $2,100 based on drug spending growth. Once you hit that number, you pay absolutely nothing for covered drugs for the rest of the year. Before this change, the so-called catastrophic coverage phase still required 5% coinsurance with no upper limit — meaning someone on expensive specialty drugs could face $10,000 or more annually. The cap includes your deductible payments, copays, and coinsurance. However, it does not include your monthly premiums, and it does not include costs for drugs that aren’t on your plan’s formulary.
This is a critical distinction for dementia caregivers to understand. If a neurologist prescribes a newer medication that isn’t covered by the plan you chose, those out-of-pocket costs won’t count toward the $2,100 threshold. You’d be paying full price with no ceiling in sight. There’s also a practical warning here: hitting the cap doesn’t mean your plan is a good deal. If you reach $2,100 in out-of-pocket costs by March because your drugs are on high tiers, you’re protected for the rest of the year — but a different plan might have kept your total annual cost well below $2,100 in the first place. The cap is a safety net, not a strategy. Always compare what you’d spend over the full year before relying on the cap to bail you out.
What Medicare’s Negotiated Drug Prices Mean for Your Prescriptions
Starting January 1, 2026, the first ten drugs negotiated under the Inflation Reduction Act are available at their new Maximum Fair Prices. The savings are substantial. Eliquis, widely prescribed for blood clot prevention, dropped from a list price of $521 per month to $231 — a 56% reduction. Jardiance, used for diabetes management, fell 66%. Xarelto dropped 62%. The full list also includes Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and NovoLog/Fiasp insulin products.
CMS estimates these negotiated prices will save approximately $1.5 billion in out-of-pocket costs for around 9 million enrollees. For dementia caregivers managing a parent’s multiple conditions, this is directly relevant. Many older adults with cognitive decline also have diabetes, atrial fibrillation, or heart failure — conditions treated by several drugs on this negotiated list. If your loved one takes Eliquis for AFib and Jardiance for diabetes, the combined savings could exceed $200 per month compared to 2023 prices. The pipeline continues: 15 additional drugs will have negotiated prices for 2027-2028, and starting in 2029, 20 more drugs will be added each year. For now, check whether any of the first ten drugs are on your medication list — and if they are, factor the new prices into your plan comparison. The negotiated price applies regardless of which Part D plan you choose, but your plan’s tier placement still determines the copay structure you’ll actually pay.
How to Use the Medicare Plan Finder Without Getting Overwhelmed
The Medicare Plan Finder at medicare.gov/plan-compare is genuinely useful, but it only works well if you bring accurate information. Before you sit down, gather every prescription bottle or pill organizer and write down the exact drug name, dosage, and how often it’s filled. Include over-the-counter medications that might have prescription alternatives covered by Part D. Have your pharmacy name and address ready. Enter each medication into the tool, confirm the dosage and quantity, and select your pharmacy. The Plan Finder will calculate estimated annual costs for every available plan in your ZIP code, accounting for premiums, deductibles, and copays specific to your drug list.
Sort by total annual cost. A plan with a $0 premium and a $615 deductible might show a total annual cost of $3,800, while a plan charging $45 per month but placing your drugs on lower tiers might total $2,200. The premium difference of $540 per year is dwarfed by the $1,600 difference in drug costs. One important tradeoff: Medicare Advantage plans with drug coverage (MA-PD) often advertise $0 drug premiums — and the average MA drug plan premium is projected at just $11.50 for 2026. But these plans bundle your medical and drug coverage together, meaning you’re also locked into their provider network for doctor visits and hospital care. For someone with dementia who has established relationships with specific neurologists or geriatricians, switching to a Medicare Advantage plan to save on drug premiums could mean losing access to those specialists. Always weigh the drug savings against the medical coverage restrictions.
Common Mistakes That Cost Dementia Families Money
The most expensive mistake is doing nothing. If you or your loved one enrolled in a Part D plan three years ago and haven’t reviewed it since, you’re almost certainly overpaying. Formularies change every year. A drug that was Tier 2 last year might be Tier 3 this year. Your plan might have been discontinued entirely — remember, 22% of standalone Part D plans disappeared between 2025 and 2026. If your plan was eliminated, you were auto-enrolled into a different one, and that replacement plan may not be the best option for your drug list. The second mistake is ignoring the late enrollment penalty. If you go 63 or more consecutive days without creditable drug coverage and later enroll in Part D, you’ll pay a penalty of 1% of the national base premium ($38.99 in 2026) for every uncovered month — permanently.
That penalty never goes away. Someone who went 24 months without coverage would pay an extra $9.36 per month, or $112 per year, for as long as they have Part D. For a person diagnosed with early-stage dementia at 68, that penalty could accumulate over 15 or more years. The third mistake is assuming all generics are cheap. Generic medications on Tier 1 typically have copays of $1 to $15. But non-preferred generics on Tier 2 can run $15 to $45, and some plans place certain generics on even higher tiers. Memantine, commonly prescribed for moderate-to-severe Alzheimer’s, is available as a generic, but the extended-release formulation may be tiered differently than the immediate-release version. Always check the specific formulation your doctor prescribes, not just the drug name.
Free Vaccines and the Insulin Cap — Benefits Easy to Overlook
Two provisions of the Inflation Reduction Act are easy to miss but valuable. All Part D-covered vaccines — including shingles, Tdap, hepatitis B, and others — now cost $0 to beneficiaries. Previously, some of these vaccines carried copays of $50 to $200. For older adults, particularly those in congregate care settings where infections spread more easily, the shingles vaccine alone is worth noting. Shingrix, the recommended two-dose shingles vaccine, had been a significant out-of-pocket expense for many seniors.
The insulin cap is equally straightforward: no more than $35 per month for covered insulin products, with no deductible applied. For 2026, the cost is set at the lower of $35 or 25% of the Maximum Fair Price. A three-month supply is capped at $105. If your family member with dementia also has diabetes requiring insulin, this cap applies automatically — but only if the insulin product is on your plan’s formulary. Verify coverage before assuming the cap applies to the specific insulin brand prescribed.
Getting Help When the Person Who Needs Coverage Can’t Manage It Alone
For families dealing with dementia, the person who most needs careful plan selection is often the least able to do it. If you have power of attorney or are an authorized representative, you can call 1-800-MEDICARE and manage plan enrollment on your loved one’s behalf. You can also use the Medicare Plan Finder with their information. Every state has a SHIP — State Health Insurance Assistance Program — that provides free, unbiased counseling from trained volunteers who can sit with you, review medications, and help compare plans. This is not a sales pitch; SHIP counselors don’t work for insurance companies. Looking ahead, the drug pricing landscape will keep shifting.
Fifteen more drugs face negotiated pricing for 2027-2028, and twenty per year after that. The average standalone Part D premium is projected to decrease from $38.31 in 2025 to $34.50 in 2026, a rare piece of good news in healthcare costs. But these averages mask wide variation — some plans in some regions will cost far more, and others far less. The only way to know what you’ll actually pay is to run your own drugs through the Plan Finder every single year during the Annual Enrollment Period, October 15 through December 7. Set a calendar reminder. Treat it like filing taxes — tedious but non-negotiable.
Conclusion
Choosing a prescription drug plan comes down to a few non-negotiable steps: list every medication with its exact name and dosage, run them through the Medicare Plan Finder, sort by total estimated annual cost, verify your pharmacy is in-network, and review the formulary tiers for your most expensive drugs. The 2026 landscape offers real improvements — a $2,100 out-of-pocket cap, negotiated prices on ten major drugs, lower average premiums, and free vaccines — but none of those benefits help if you’re enrolled in a plan that doesn’t cover your prescriptions well. For dementia families, this process carries extra weight.
Cognitive decline doesn’t pause while you sort out insurance paperwork, and medication adherence — already a challenge with memory loss — gets harder when cost barriers lead to skipped doses or unfilled prescriptions. Do the comparison work now, during open enrollment. Use SHIP counselors if you need a second set of eyes. And revisit the decision every year, because the plan that worked last year may not be the right one next year.
